Citations

Showing 10 of 108104 citations.

Alzheimer’s disease associated AKAP9 I2558M mutation alters posttranslational modification and interactome of tau and cellular functions in CRISPR‐edited human neuronal cells
You, Yang , Hersh, Samuel, Aslebagh, Roshanak, Ikezu, Seiko , Ikezu, Tsuneya , Ikezu, Tsuneya , Yang, You , Shaffer, Scott A. , Mez, Jesse , Lunetta, Kathryn L. , Logue, Mark W. , Farrer, Lindsay A.

Mayo Clinic

Aging Cell | May 14, 2022 | Volume: 21 | Issue: 6 | Pages: No page available

10.1111/acel.13617 | PMID 35567427 Get It

AbstractAlzheimer's disease (AD) is a pervasive neurodegeneration disease with high heritability. In this study, we employed CRISPR‐Cas9‐engineered technology to investigate the effects of a rare mutation (rs144662445) in the A kinase anchoring protein 9 (AKAP9) gene, which is associated with AD in African Americans (AA), on tau pathology and the tau interactome in SH‐SY5Y P301L neuron‐like cells. The mutation significantly increased the level of phosphorylated tau, specifically at the site Ser396/Ser404. Moreover, analyses of the tau interactome measured by affinity purification‐mass spectrometry revealed that differentially expressed tau‐interacting proteins in AKAP9 mutant cells were associated with RNA translation, RNA localization and oxidative activity, recapitulating the tau interactome signature previously reported with human AD brain samples. Importantly, these results were further validated by functional studies showing a significant reduction in protein synthesis activity and excessive oxidative stress in AKAP9 mutant compared with wild type cells in a tau‐dependent manner, which are mirrored with pathological phenotype frequently seen in AD. Our results demonstrated specific effects of rs14462445 on mis‐processing of tau and suggest a potential role of AKAP9 in AD pathogenesis.
Contribution of Verbal Learning & Memory and Spectro‐Temporal Discrimination to Speech Recognition in Cochlear Implant Users
Harris, Michael S. , Hamel, Benjamin , Wichert, Kristin, Kozlowski, Kristin, Mleziva, Sarah, Ray, Christin , Pisoni, David B. , Moberly, Aaron C. , Hamel, Benjamin L, Moberly, Aaron C , Harris, Michael S , Kronenberger, William G.

Mayo Clinic

The Laryngoscope | May 14, 2022 | Volume: 133 | Issue: 3 | Pages: 661-669

10.1002/lary.30210 | PMID 35567421 Get It

ObjectivesExisting cochlear implant (CI) outcomes research demonstrates a high degree of variability in device effectiveness among experienced CI users. Increasing evidence suggests that verbal learning and memory (VL&M) may have an influence on speech recognition with CIs. This study examined the relations in CI users between visual measures of VL&M and speech recognition in a series of models that also incorporated spectro‐temporal discrimination. Predictions were that (1) speech recognition would be associated with VL&M abilities and (2) VL&M would contribute to speech recognition outcomes above and beyond spectro‐temporal discrimination in multivariable models of speech recognition.MethodsThis cross‐sectional study included 30 adult postlingually deaf experienced CI users who completed a nonauditory visual version of the California Verbal Learning Test‐Second Edition (v‐CVLT‐II) to assess VL&M, and the Spectral‐Temporally Modulated Ripple Test (SMRT), an auditory measure of spectro‐temporal processing. Participants also completed a battery of word and sentence recognition tasks.ResultsCI users showed significant correlations between some v‐CVLT‐II measures (short‐delay free‐ and cued‐recall, retroactive interference, and “subjective” organizational recall strategies) and speech recognition measures. Performance on the SMRT was correlated with all speech recognition measures. Hierarchical multivariable linear regression analyses showed that SMRT performance accounted for a significant degree of speech recognition outcome variance. Moreover, for all speech recognition measures, VL&M scores contributed independently in addition to SMRT.ConclusionMeasures of spectro‐temporal discrimination and VL&M were associated with speech recognition in CI users. After accounting for spectro‐temporal discrimination, VL&M contributed independently to performance on measures of speech recognition for words and sentences produced by single and multiple talkers.Level of Evidence3 Laryngoscope, 133:661–669, 2023
Multiple Consecutive Cervicovaginal Cytology Specimens Confirm Persistent Colonization by Cokeromyces recurvatus: Case Report and Literature Review
Lor, Keng, Hartley, Christopher , Kemp, Anna M., Swanson, Amy A. , Sturgis, Charles D. , Hartley, Christopher P., Sturgis, Charles D , Hartley, Christopher P , Pritt, Bobbi S.

Mayo Clinic

Case Reports in Pathology | May 14, 2022 | Volume: 2022 | Issue: No issue available | Pages: 1-4

10.1155/2022/2151926 | PMID 35599911 Get It

The published literature on cervicovaginal cytology includes fewer than ten reported cases of Cokeromyces recurvatus identified in Pap test samples. We report a unique case of an asymptomatic 27-year-old female with persistent gynecologic tract colonization by C. recurvatus in which distinctive fungal microorganisms were identified in three samples collected over three consecutive years.
Tunneling Nanotube-Mediated Communication: A Mechanism of Intercellular Nucleic Acid Transfer
Driscoll, Julia , Gondaliya, Piyush , Patel, Tushar , Patel, Tushar

Mayo Clinic

International Journal of Molecular Sciences | May 14, 2022 | Volume: 23 | Issue: 10 | Pages: 5487

10.3390/ijms23105487 | PMID 35628298 Get It

Tunneling nanotubes (TNTs) are thin, F-actin-based membranous protrusions that connect distant cells and can provide e a novel mechanism for intercellular communication. By establishing cytoplasmic continuity between interconnected cells, TNTs enable the bidirectional transfer of nuclear and cytoplasmic cargo, including organelles, nucleic acids, drugs, and pathogenic molecules. TNT-mediated nucleic acid transfer provides a unique opportunity for donor cells to directly alter the genome, transcriptome, and metabolome of recipient cells. TNTs have been reported to transport DNA, mitochondrial DNA, mRNA, viral RNA, and non-coding RNAs, such as miRNA and siRNA. This mechanism of transfer is observed in physiological as well as pathological conditions, and has been implicated in the progression of disease. Herein, we provide a concise overview of TNTs’ structure, mechanisms of biogenesis, and the functional effects of TNT-mediated intercellular transfer of nucleic acid cargo. Furthermore, we highlight the potential translational applications of TNT-mediated nucleic acid transfer in cancer, immunity, and neurological diseases.
MicroPET Imaging Assessment of Brain Tau and Amyloid Deposition in 6 × Tg Alzheimer’s Disease Model Mice
Kang, Shinwoo , Kim, Jinho , Lee, Sang‐Yoon , Okamura, Nobuyuki , Chang, Keun‐A

Mayo Clinic

International Journal of Molecular Sciences | May 14, 2022 | Volume: 23 | Issue: 10 | Pages: 5485

10.3390/ijms23105485 | PMID 35628296 Get It

Alzheimer’s disease (AD) is characterized by the deposition of extracellular amyloid plaques and intracellular accumulation of neurofibrillary tangles (NFT). Amyloid beta (Aβ) and tau imaging are widely used for diagnosing and monitoring AD in clinical settings. We evaluated the pathology of a recently developed 6 × Tg − AD (6 × Tg) mouse model by crossbreeding 5 × FAD mice with mice expressing mutant (P301L) tau protein using micro-positron emission tomography (PET) image analysis. PET studies were performed in these 6 × Tg mice using [18F]Flutemetamol, which is an amyloid PET radiotracer; [18F]THK5351 and [18F]MK6240, which are tau PET radiotracers; moreover, [18F]DPA714, which is a translocator protein (TSPO) radiotracer, and comparisons were made with age-matched mice of their respective parental strains. We compared group differences in standardized uptake value ratio (SUVR), kinetic parameters, biodistribution, and histopathology. [18F]Flutemetamol images showed prominent cortical uptake and matched well with 6E10 staining images from 2-month-old 6 × Tg mice. [18F]Flutemetamol images showed a significant correlation with [18F]DPA714 in the cortex and hippocampus. [18F]THK5351 images revealed prominent hippocampal uptake and matched well with AT8 immunostaining images in 4-month-old 6 × Tg mice. Moreover, [18F]THK5351 images were confirmed using [18F]MK6240, which revealed significant correlations in the cortex and hippocampus. Uptake of [18F]THK5351 or [18F]MK6240 was highly correlated with [18F]Flutemetamol in 4-month-old 6 × Tg mice. In conclusion, PET imaging revealed significant age-related uptake of Aβ, tau, and TSPO in 6 × Tg mice, which was highly correlated with age-dependent pathology.
Review article: current and emerging therapies for acute alcohol‐associated hepatitis
Rattan, Puru , Shah, Vijay H.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | May 14, 2022 | Volume: 56 | Issue: 1 | Pages: 28-40

10.1111/apt.16969 | PMID 35567372 Get It

SummaryBackgroundAlcohol‐associated hepatitis is an acute manifestation of alcohol‐associated liver disease (ALD) and is associated with 30%–40% mortality at 28 days. Abstinence and corticosteroids are the mainstays of treatment, but the latter only improves short‐term mortality, so new and improved therapies remain an unmet need.AimsThe aim was to review the pathophysiology of alcohol‐associated hepatitis and how various targets can be used by current and emerging therapies as treatment.MethodsA thorough literature review was conducted on acute alcohol‐associated hepatitis, current therapies and therapies under investigation.ResultsWith the increasing prevalence of alcohol use disorder and ALD, the burden of alcohol‐associated hepatitis is also expected to rise. The current understanding of alcohol‐associated hepatitis pathophysiology has led to clinical trials of several therapies involving IL‐1 antagonism, modification of the gut microbiome and liver regeneration.ConclusionsCorticosteroid therapy for alcohol‐associated hepatitis is restricted in its applicability and has limited efficacy. Developing multidisciplinary, patient‐centred care models based on digital health technologies, in combination with continued discovery of novel therapies using multiomics data and computational biology techniques will be necessary to tackle the increasing burden of alcohol‐associated hepatitis.
Perforated Meckel Diverticulum
Mousa, Abeer A, Mousa, Mohammad, Towbin, Richard B. , Li, Yinan , Schaefer, Carrie M. , Towbin, Alexander J.

Mayo Clinic

Applied Radiology | May 14, 2022 | Volume: No volume available | Issue: No issue available | Pages: 53-55

10.37549/ar2815 Get It

Efficacy and safety of endoscopic ultrasound-guided gastrojejunostomy in patients with malignant gastric outlet obstruction and ascites
Mahmoud, Tala , Law, Ryan , Jaruvongvanich, Veeravich , Ghazi, Rabih , Abusaleh, Rami , Levy, Michael J. , Truty, Mark J. , Law, Ryan J, Storm, Andrew C. , Vargas, Eric J. , Bazerbachi, Fateh , Levy, Michael J. , Chandrasekhara, Vinay , Dayyeh, Barham K. Abu

Mayo Clinic

Endoscopy International Open | May 13, 2022 | Volume: 10 | Issue: 05 | Pages: E670-E678

10.1055/a-1797-9318 | PMID 35571468 Get It

Abstract Background and study aims Endoscopic ultrasound-guided gastrojejunostomy (EUS-GJ) is an endoscopic procedure for treating gastric outlet obstruction (GOO). Limited data exist regarding the safety and efficacy of EUS-GJ in patients with malignant GOO with ascites. Thus, we aimed to study the outcomes and safety of EUS-GJ in GOO patients with vs. without ascites. Patients and methods This is a retrospective cohort study of patients with malignant GOO who underwent successful EUS-GJ at a tertiary care academic center. Primary outcomes included the efficacy and safety of EUS-GJ. Secondary outcomes included 30-day readmission, reintervention, and survival utilizing Kaplan-Meier analysis. Results A total of 55 patients (mean age of 67.0 ± 11.3 years, 40.0 % female) who underwent EUS-GJ, of whom 24 had ascites (small in 22, large in 2) were included. Clinical success was achieved in 91.7 % and 93.5 % (P = 1.00) of patients with and without ascites, respectively. A higher rate of adverse events (AEs) was noted in patients with ascites but this was not statistically significant (37.5 % vs. 19.4 %, P = 0.13). Four patients in the ascites group (16.6 %) developed clinical evidence of peritonitis or sepsis post-EUS-GJ. Eight patients with ascites developed worsening ascites within a month of EUS-GJ. In contrast, only one patient without ascites developed evidence of new ascites. The median survival of patients was not significantly different between the two groups (patients with ascites: 129 days vs. patients without ascites: 180 days, (P = 0.12). Conclusions The efficacy EUS-GJ in the presence of ascites is promising; however, the safety profile remains concerning given the high rate of AEs, specifically peritonitis and sepsis.
Women’s Experience With Screening Mammography During the COVID-19 Pandemic: A Multi-Institutional Prospective Survey Study
Carnahan, Molly B. , Parra, Laura , Hippe, Daniel S. , Lorans, Roxanne, Perry, Hannah , Moey, Tammy Hui Lin , Bagadiya, Neeti, Lee, Janie M. , Sharpe, Richard E. , Hippe, Daniel S , Moey, Tammy Hui Lin , Harrison, Molly , Oluyemi, Eniola T.

Mayo Clinic

Journal of Breast Imaging | May 13, 2022 | Volume: 4 | Issue: 3 | Pages: 253-262

10.1093/jbi/wbac022 | PMID 38416975 Get It

Abstract Objective Evaluate women’s anxiety and experience undergoing screening mammography during the COVID-19 pandemic. Methods An IRB-approved anonymous survey was administered to women receiving screening mammography across six sites in the U.S. and Singapore from October 7, 2020, to March 11, 2021. Using a 1–5 Likert scale, women rated their pre- and post-visit anxiety regarding having their mammogram during the COVID-19 pandemic, importance of observed COVID-19 precautions, and personal risk factors for breast cancer and severe COVID-19 illness. Post-visit change in anxiety was evaluated. Multivariable logistic regression was used to test associations of pre-visit anxiety with breast cancer and COVID-19 risk factors. Results In total, 1086 women completed the survey. Of these, 59% (630/1061) had >1 breast cancer risk factor; 27% (282/1060) had >1 COVID-19 risk factors. Forty-two percent (445/1065) experienced pre-visit anxiety. Pre-visit anxiety was independently associated with risk factors for severe COVID-19 (OR for >2 vs 0 risk factors: 2.04, 95% confidence interval [CI]: 1.11–3.76) and breast cancer (OR for >2 vs 0 risk factors: 1.71, 95% CI: 1.17–2.50), after adjusting for age and site. Twenty-six percent (272/1065) of women reported post-visit anxiety, an absolute 16% decrease from pre-visit anxiety (95% CI: 14%–19%, P < 0.001). Provider masking (941/1075, 88%) and physical distancing (861/1085, 79%) were rated as the most important precautions. Conclusion Pre-visit anxiety was associated with COVID-19 or breast cancer risk factors and declined significantly after screening mammography. Provider masking and physical distancing were rated the most important precautions implemented by imaging clinics.